BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mor Z, Srur S, Dagan R, Rishpon S. Hepatitis A disease following the implementation of universal vaccination: who is at risk? J Viral Hepat. 2010;17:293-297. [PMID: 19691457 DOI: 10.1111/j.1365-2893.2009.01176.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Cervio G, Trentadue J, D'Agostino D, Luque C, Giorgi M, Armoni J, Debbag R. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med 2011;3:99-106. [PMID: 24367225 DOI: 10.2147/HMER.S22309] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
2 Aldea Novo M, Bayas Rodríguez J, Moraga-llop F. Programas de vacunación universal contra la hepatitis A en el mundo. Vacunas 2012;13:150-62. [DOI: 10.1016/s1576-9887(12)70057-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ben-Shimol S, Dagan R, Schonmann Y, Givon-Lavi N, Keller N, Block C, Kassis I, Ephros M, Greenberg D. Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010). Infection 2013;41:791-8. [PMID: 23475472 DOI: 10.1007/s15010-013-0439-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012;30:6600-6607. [PMID: 22939907 DOI: 10.1016/j.vaccine.2012.08.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
5 Mor Z, Lurie Y, Katchman E. A case of hepatitis a vaccination failure in an HIV-positive man who had sex with men in Israel. Int J STD AIDS 2012;23:529-30. [DOI: 10.1258/ijsa.2010.010269] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
6 Mongillo M, Chiara F, Ranzato M, Trevisan A. Strategy for hepatitis A seroprevalence survey in a population of young people. Vaccine 2010;28:6985-8. [PMID: 20732467 DOI: 10.1016/j.vaccine.2010.08.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Levine H, Kopel E, Anis E, Givon-Lavi N, Dagan R. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012. Euro Surveill 2015;20:3-10. [PMID: 25719962 DOI: 10.2807/1560-7917.es2015.20.7.21040] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
8 Lee YL, Lin KY, Cheng CY, Li CW, Yang CJ, Tsai MS, Tang HJ, Lin TY, Wang NC, Lee YC, Lin SP, Huang YS, Sun HY, Zhang JY, Ko WC, Cheng SH, Lee YT, Liu CE, Hung CC; Taiwan HIV Study Group. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS One 2017;12:e0186338. [PMID: 29036227 DOI: 10.1371/journal.pone.0186338] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3): 68-73 [PMID: 22489258 DOI: 10.4254/wjh.v4.i3.68] [Cited by in Crossref: 157] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
10 Xu ZY, Wang XY. Live attenuated hepatitis A vaccines developed in China. Hum Vaccin Immunother 2014;10:659-66. [PMID: 24280971 DOI: 10.4161/hv.27124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]